Riskpilot← Back to searchSign inGet full accessTestilabs Oy
OYActiveY-tunnus 2795434-9Elektroniikkatie 17Technical testing and analysis · NACE 7120Est. 20161 employees
Revenue 2024
EUR 571K
-9% vs 2023
EBITDA margin
0.3%
-95% vs 2023
Equity ratio
42.8%
Financial strength
Net profit 2024
EUR 1K
-97% vs 2023
| Revenue | EUR 571K | -9% |
| EBITDA | EUR 2K | -95% |
| Net profit | EUR 1K | -97% |
| Total assets | EUR 169K | -99% |
| Equity | EUR 72K | -99% |
| Employees | 1 | — |
Legal name
Testilabs Oy
Y-tunnus number
2795434-9
Legal form
Osakeyhtiö
NACE code
7120 · Technical testing and analysis
Founded
17. marraskuuta 2016
Share capital
EUR 3 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on Testaus- ja analysointipalveluiden tuottaminen, markkinointi ja myynti sekä kaikki muu laillinen liiketoiminta.
Address
Elektroniikkatie 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 718 | 1 076 | 783 | 629 | 571 |
| Staff expenses | −115 | −130 | −47 | −8 | −44 |
| EBITDA | 7 | 3 | 47 | 41 | 2 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 7 | 3 | 47 | 41 | 2 |
| Net financials | −1 | −1 | −0 | −0 | −0 |
| Profit before tax | 6 | 2 | 47 | 40 | 2 |
| Tax | 1 | 0 | 9 | 8 | 0 |
| Net profit | 5 | 1 | 37 | 32 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 299 | 237 | 167 | 13 475 | 169 |
| Equity | 9 | 11 | 48 | 7 585 | 72 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 290 | 226 | 119 | 5 890 | 97 |
| Total debt | 290 | 226 | 119 | 5 890 | 97 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20202024
Equity ratio
42.8%
This company
38.2%
Market median
+12% vs market
20202024
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20202024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20202024
Asset turnover
3.37×
This company
1.12×
Market median
+201% vs market
20202024
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Deputy Member | Deputy Member | 2022 |
MM Deputy Member | Deputy Member | 2022 |
| Former (1) | ||
HR | Audit | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Testilabs Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tommi Kristian Kiviniemi | Deputy Member | 0 companies |
| Miia Marjaana Nurkkala | Deputy Member | 0 companies |
| Heidi Riikka Hannele Hyry | Audit | 0 companies |
| Kari-Matti Jokinen | Board of Directors | 0 companies |
| Mika Petri Pajarinen | Chairperson | 0 companies |
| Tapio Kalevi Laurila | Board of Directors | 0 companies |
| Kari Unto Juhani Komonen | Board of Directors | 0 companies |